These Cells Have Hidden Powers That Could Heal Brain Injuries
Novel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free
UCSF Health transplant specialists recently performed an innovative, minimally invasive pancreatic islet transplant designed to enable a patient with Type 1 diabetes to become insulin independent.
The patient received insulin-producing islets created in a laboratory and derived from stem cells of an individual with the same blood type. While UCSF Health is internationally known for islet transplantation, the islets have previously come from deceased donor pancreases.
Starve Tumors? How to Kill Cancer by Cutting Off Its Energy Supply
Study Assesses Cancers in Children Exposed to Medical Imaging
Danger: Pesticides Raise Death Risk 60% for Kids with Leukemia
Can CRISPR Fix a Childhood Brain Disorder?
Vizient Gives UCSF Health High Marks for Patient Care Excellence
UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a combined program focused on cancer outcomes. The program will receive $12 million over five years to improve cancer health outcomes across populations by investigating the interplay of tumor biology with individual risk factors and external drivers of health.
Repurposing a Diabetes Medication to Prime CAR T Cancer Targets
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC remains around 5% to 10%.